Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy Followed by Tirbanibulin for Actinic Keratosis
NCT07273656Phase 3Not yet recruiting
- Sponsor
- CHU de Lille
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tirbanibulin in actinic keratosis (AK), sponsored by CHU de Lille. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
tirbanibulin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT07273656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07273656.